Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jun 01, 2005

Mylan Laboratories Receives Approvable Letter For Its Next Generation Beta-Blocker Nebivolol

May 20, 2005

Mylan Laboratories Names John Deiriggi Vice President of Generic Business Development

May 18, 2005

New Data on Mylan Bertek's Investigational Beta-Blocker Compound, Nebivolol, Presented at the American Society of Hypertension Meeting

May 12, 2005

Mylan Reports Fiscal 2005 Earnings Per Diluted Share of $0.74 -- Announces Investor Presentation and Non-Deal Roadshow Scheduled for June 14, 2005

May 11, 2005

Mylan Laboratories Names Patrick Fitzgerald Vice President, Public Relations

Apr 18, 2005

Mylan Receives Approval for Anagrelide Hydrochloride Capsules

Apr 15, 2005

Mylan Announces Tentative Approval for Terbinafine Hydrochloride Tablets

Apr 01, 2005

Mylan Receives Approval for Quinapril Hydrochloride and Hydrochlorothiazide Tablets

Mar 29, 2005

Mylan Receives Tentative Approval for Olanzapine Tablets

Mar 17, 2005

Mylan Declares Quarterly Cash Dividend

Pagination

First page
Previous page
…
Page 109
Page 110
Page 111
Page 112
Current page 113
Page 114
Page 115
Page 116
Page 117
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.